Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS – Get Free Report) was the recipient of a large decline in short interest during the month of August. As of August 14th, there was short interest totaling 3,753 shares, a decline of 80.3% from the July 30th total of 19,077 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 144,592 shares, the days-to-cover ratio is presently 0.0 days.
Hedge Funds Weigh In On Neuberger Berman High Yield Strategies Fund
A number of hedge funds have recently added to or reduced their stakes in NHS. Rivernorth Capital Management LLC grew its stake in shares of Neuberger Berman High Yield Strategies Fund by 2,185.7% in the second quarter. Rivernorth Capital Management LLC now owns 1,371,413 shares of the investment management company’s stock worth $8,558,000 after acquiring an additional 1,311,413 shares during the period. Cable Car Capital LP purchased a new stake in Neuberger Berman High Yield Strategies Fund in the second quarter worth approximately $1,455,000. Guggenheim Capital LLC grew its position in Neuberger Berman High Yield Strategies Fund by 38.0% in the 4th quarter. Guggenheim Capital LLC now owns 567,943 shares of the investment management company’s stock worth $4,225,000 after purchasing an additional 156,386 shares during the period. Readystate Asset Management LP bought a new stake in Neuberger Berman High Yield Strategies Fund in the 2nd quarter worth approximately $325,000. Finally, Equitable Holdings Inc. purchased a new stake in Neuberger Berman High Yield Strategies Fund during the 2nd quarter valued at $287,000.
Neuberger Berman High Yield Strategies Fund Stock Performance
NHS stock remained flat at $5.95 during trading on Thursday. 99,306 shares of the company traded hands, compared to its average volume of 225,968. Neuberger Berman High Yield Strategies Fund has a one year low of $5.91 and a one year high of $7.75. The stock has a 50-day simple moving average of $6.09 and a 200 day simple moving average of $6.53.
Neuberger Berman High Yield Strategies Fund Announces Dividend
About Neuberger Berman High Yield Strategies Fund
The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.
Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.
Featured Stories
- Five stocks we like better than Neuberger Berman High Yield Strategies Fund
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Neuberger Berman High Yield Strategies Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strategies Fund and related companies with MarketBeat.com's FREE daily email newsletter.
